Cethromycin

DB06419InvestigationalSmall molecule

Cethromycin is a ketolide antibiotic with broad-spectrum activity against Gram-positive, Gram-negative, and atypical bacteria that may be useful for treating several conditions including community-acquired pneumonia, inhalation anthrax, plague, and tularemia. Cethromycin is a 3-keto (ketolide) derivative of erythromycin A with an 11,12-carbamate group and an O-6-linked aromatic ring system.

Chemical structure of Cethromycin
Mechanism
Curator reviewed · 3 references
Primary indication
Cethromycin currently has no FDA-approved indications; it was granted orphan drug designation for the prophylactic treatment of inhalation anthrax in 2007 and for the prophylactic treatment of both plague due to Yersinia pestis and tularemia...Curator reviewed · 3 structured indications
Formula / weight
C42H59N3O10 · 765.945 g/mol (avg)
Code names
A-195773 · ABBOTT-195773 · ABT-773

Resolves to

Structure
InChIKeyPENDGIOBPJLVBT-AMXFZXBBSA-NSMILES[H]C(CO[C@]1(C)C[C@@H](C)C(=O)[C@H](C)[C@H]2NC(=O)O[C@]2(C)[C@@H](CC)OC(=O)[C@H](C)C(=O)[C@H](C)[C@H]1O[C@@H]1O[C@H](C)C[C@@H]([C@H]1O)N(C)C)=C([H])C1=CC2=C(C=CC=C2)N=C1
Transporters

What you can answer from here — as of February 21, 2021

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1TransporterSubstrate / inhibitor direction, not just membership
Listed above
692Drug interactionsStructured to mechanism, not free text
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
3Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
20+ReferencesStructured and connected to the statements they support
Sign in

Which other approved drugs treat the same conditions as Cethromycin, and which companies have late-stage candidates in those indications?

Create a free account or log in to explore the full data card.

Create Account